These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 22460058)

  • 21. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema.
    Goldberg JI; Wiechmann LI; Riedel ER; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2010 Dec; 17(12):3278-86. PubMed ID: 20574774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema.
    Goldberg JI; Riedel ER; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2011 Oct; 18(10):2866-72. PubMed ID: 21465310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.
    Krishnan MS; Recht A; Bellon JR; Punglia RS
    Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH; Fey JV; Borgen PI; Van Zee KJ
    Oncol Nurs Forum; 2004 Jul; 31(4):691-8. PubMed ID: 15252425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
    Boneti C; Badgwell B; Robertson Y; Korourian S; Adkins L; Klimberg V
    Minerva Ginecol; 2012 Oct; 64(5):421-30. PubMed ID: 23018481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
    Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
    Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
    Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
    Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.